Phase 1 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma

Phase 1 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma

Sponsor(s)

Nereus Pharmaceuticals

Principal Investigator(s)Jonathan L Kaufman, MD
Dates9/02/2009 - 12/31/2013